XML 50 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Acquisitions - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2025
USD ($)
Jul. 31, 2025
USD ($)
Nov. 30, 2024
USD ($)
contract
inProcessResearchAndDevelopmentAsset
shares
Sep. 30, 2025
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Mar. 31, 2025
Nov. 20, 2024
$ / shares
Business Combination [Line Items]                
Loss on disposal of a business         $ 4,502 $ 0    
Share price (in dollars per share) | $ / shares               $ 6.04
Additions         5,947      
Exscientia Plc                
Business Combination [Line Items]                
Business combination, consideration transferred     $ 630,100          
Recursion Class A common stock     616,900          
Fair value of stock and equity awards     $ 13,200          
Equity interest issued or issuable (in shares) | shares     102,100,000          
Additions         6,000      
Increase deferred tax liabilities         6,000      
Number of acquired customer contracts with contract liabilities | contract     2          
Number of in-process research and development assets | inProcessResearchAndDevelopmentAsset     4          
Discount rate (as a percent)     10.50%          
Net revenues         16,800      
Operating loss         139,400      
Exscientia Plc | Definite-lived technology intangible assets                
Business Combination [Line Items]                
Useful life (in years)     6 years          
Exscientia Plc | Class A Common Stock                
Business Combination [Line Items]                
Shares of acquirer stock per share of acquiree stock outstanding (in shares) | shares     0.7729          
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Exscientia GmbH                
Business Combination [Line Items]                
Loss on disposal of a business         4,500      
Alpha Biotechnology GmbH (Alpha)                
Business Combination [Line Items]                
Equity method investment ownership percentage             49.00%  
Equity method investments       $ 4,400 $ 4,400      
RE Ventures I                
Business Combination [Line Items]                
Interest acquired   100.00%            
Asset acquisition, consideration transferred   $ 20,153            
Payments to acquire IPR&D $ 2,400     $ 20,200